Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

3-Fluoro-Deoxyglucose for the assessment of cerebral perfusion and glucose transport - Indications for extracranial-intracranial arterial bypass and followup studies

Conference · · J. Nucl. Med.; (United States)
OSTI ID:7064654

3-Fluor-Deoxyglucose (3FDG) is a glucose-analogue which is transported across the blood-brain-barrier by the same carrier as glucose but is only phoshorylated to a minor part. By a newly developed model, it became possible to estimate both cerebral perfusion and glucose transport in a single examination, determining the Michaelis-Menten-constant K/sub M/ and the maximal velocity v/sub m/. Normal values were determined as follows: gray matter perfusion 88+-8 ml/ 100g min; v/sub m/ was 2.46 ..mu..mol/g min; K/sub M/ was 6.42 ..mu..mol/g. This method was applied successfully in a series of 15 patients with cerebral ischemia to select suitable candidates for extacranial-intracranial (EC-IC) arterial bypass surgery and to follow them up to 15 months postop. In patients with minor strokes and transient ischemic attacks (TIA), areas which appeared normal in conventional CT presented with reduced perfusion values (down to 67 ml/ 100 g min) and either normal or reduced v/sub m/ (down to 0.8 ..mu..mol/g min). These patients were thought optimal candidates for EC-IC bypass in order to improve the misery perfusion rate.

Research Organization:
Univ. of Essen Medical Center, Essen, Herzzentrum NRW, Bad Oeynhausen
OSTI ID:
7064654
Report Number(s):
CONF-850611-
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 26:5; ISSN JNMEA
Country of Publication:
United States
Language:
English